ArticleAlzheimer's & dementia (New York, N. Y.)

FDA approval of Miplyffa and Aqneursa: A dual breakthrough for the treatment of Neimann-Pick disease type C.

Mahnoor Jan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.